Effect of the Subconscious on Mohs Micrographic Surgery
1 other identifier
interventional
150
1 country
1
Brief Summary
The goal of this study is to determine if relaxation therapy improves patient satisfaction with Mohs micrographic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2006
CompletedFirst Posted
Study publicly available on registry
September 8, 2006
CompletedStudy Start
First participant enrolled
December 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedJuly 15, 2014
July 1, 2014
1.7 years
September 7, 2006
July 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient anxiety
1 day
Secondary Outcomes (1)
Scar appearance
12 weeks
Study Arms (3)
I
EXPERIMENTALrelaxation tape 1
II
EXPERIMENTALrelaxation tape 2
III
PLACEBO COMPARATORrelaxation tape 3
Interventions
Eligibility Criteria
You may qualify if:
- Age 25 and older
- Subjects are undergoing micrographic Mohs surgery for facial basal and squamous cell carcinoma.
- The subjects are in good health.
- The subjects have willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
You may not qualify if:
- Subjects who have wound healing problems.
- Subjects who have had prior Mohs surgery.
- Subjects who are smokers.
- Subjects who are currently using anticoagulation therapy
- Subjects who have a history of bleeding disorders.
- Subjects who are unable to understand the protocol or to give informed consent
- Subjects with known mental illness or other psychological conditions, such as psychotic disorders, mood disorders, anxiety disorders, cognitive disorders, depression with psychotic features, dissociative disorders.
- Subjects who are taking medications that may affect healing such as prednisone, or any immunosuppressants.
- Subjects who are immunocompromised.
- Subjects who have Diabetes Mellitus or any other condition determined by the PI to affect healing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Murad Alam, MD
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Murad Alam, MD
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 7, 2006
First Posted
September 8, 2006
Study Start
December 1, 2007
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
July 15, 2014
Record last verified: 2014-07